Synthesis of ( Z )- N -hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

M. V. Kozlov; A. A. Kleymenova; K. A. Konduktorov; A. Z. Malikova; K. A. Kamarova; R. A. Novikov; S. N. Kochetkov

doi:10.1134/S1068162016010076

Synthesis of (Z)-N-hydroxy-3-methoxy-3-phenylacrylamide as new selective inhibitor of hepatitis C virus replication

Авторы: Kozlov M.V.¹, Kleymenova A.A.¹, Konduktorov K.A.¹, Malikova A.Z.¹, Kamarova K.A.¹, Novikov R.A.¹, Kochetkov S.N.¹
Учреждения:
1. Engelhardt Institute of Molecular Biology
Выпуск: Том 42, № 2 (2016)
Страницы: 191-197
Раздел: Article
URL: https://journals.rcsi.science/1068-1620/article/view/227875
DOI: https://doi.org/10.1134/S1068162016010076
ID: 227875

Цитировать

Полный текст

Открытый доступ
Доступ закрыт

Доступ предоставлен
Доступ закрыт

Только для подписчиков

Аннотация
Об авторах
Список литературы
Дополнительные файлы
Статистика

Аннотация

According to recently published results, cinnamic hydroxamic acid (CHA) inhibits replication of hepatitis C virus (HCV). We synthesized a structural analogue of CHA, i.e., (Z)-N-hydroxy-3-methoxy3-phenylacrylamide, which inhibited HCV replication five times more selectively than CHA. It was found that both compounds did not inhibit deacetylation of Ac-α-tubulin with histone deacetylase 6, the activity of which is important for virus replication.